Recruiting
Phase 2
Phase 3

Linsitinib

Sponsor:

Sling Therapeutics, Inc.

Code:

NCT06112340

Conditions

Thyroid Eye Disease

Graves Orbitopathy

Endocrine System Diseases

Eye Diseases

Thyroid Associated Ophthalmopathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

linsitinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information